Published in AIDS Weekly, August 10th, 1998
E. Franck Matheux, representing colleagues from the Leclerl Fontenay, France, presented data from their animal study of HIV gene therapy at the 12th World AIDS Conference, held June 28 - July 3, 1998, in Geneva, Switzerland (abstract "AIDS Gene Therapy Based on Antiviral Properties of IFN-(beta): Efficiency in the SIV Model").
"We are exploring a gene therapy approach based on low and constitutive expression of IFN-(beta) in HIV target cells (Vieillard et al., AIDS 1995;9:1221),"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.